Ernexa Therapeutics Inc. — SCHEDULE 13D/A Filings
4 SCHEDULE 13D/A filings on record
This page lists all SCHEDULE 13D/A filings submitted to the SEC by Ernexa Therapeutics Inc. (ERNAW), sorted by most recent first. Each row links to the full filing on EdgarLookup. Ernexa Therapeutics Inc. has filed 4 SCHEDULE 13D/A documents with the SEC since 2009. To view all SEC filings by Ernexa Therapeutics Inc., see the full filings list.
All
10-K
10-K/A
10-K405
10-Q
10-Q/A
15-12G
25
3
3/A
4
4/A
424B3
424B5
425
5
8-A12B
8-A12B/A
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DEFR14A
DEFS14A
DRS
EFFECT
NT 10-K
NT 10-K/A
NT 10-Q
POS AM
PRE 14A
PRES14A
REGDEX
RW
S-1
S-1/A
S-3
S-3/A
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13D/A | — | 0001104659-26-016685 | Feb 17, 2026 | — |
| SCHEDULE 13D/A | — | 0001104659-25-058646 | Jun 11, 2025 | — |
| SCHEDULE 13D/A | — | 0001104659-25-032062 | Apr 4, 2025 | — |
| SCHEDULE 13D/A | — | 0001104659-25-020984 | Mar 5, 2025 | — |